SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021
Tran TN, Wikle NB, Yang F, Inam H, Leighow S, Gentilesco B, Chan P, Albert E, Strong ER, Pritchard JR, Hanage WP, Hanks EM, Crawford FW, Boni MF. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021. JAMA Network Open 2022, 5: e2214171. PMID: 35616938, PMCID: PMC9136627, DOI: 10.1001/jamanetworkopen.2022.14171.Peer-Reviewed Original ResearchConceptsHigh vaccine coveragePopulation immunityPublic health agenciesVaccine coverageVaccination campaignMAIN OUTCOMECOVID-19 positive test resultsSARS-CoV-2 attack ratesIntensive care unit occupancyHealth agenciesLarge epidemic waveProportion of vaccinesAttack rateObservational case seriesPopulation-level immunitySARS-CoV-2Median ageCase seriesCOVID-19 casesPercentage of individualsVaccination planningDelta variantOngoing epidemicPandemic settingVaccineVaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Prunas O, Warren JL, Crawford FW, Gazit S, Patalon T, Weinberger DM, Pitzer VE. Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science 2022, 375: eabl4292. PMID: 35084937, PMCID: PMC9261115, DOI: 10.1126/science.abl4292.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Syndrome coronavirus 2Effectiveness of vaccinesEffectiveness of vaccinationTotal vaccine effectivenessSARS-CoV-2Household contactsSecond doseCoronavirus 2Household transmissionDelta variantDay 10VaccinationBNT162b2COVID-19InfectionChain binomial modelVaccineDoseImmunity